Jury Awards More Than $1.5 Billion In Talc Verdict

A Baltimore jury delivered a substantial verdict on December 23, awarding Cherie Craft of Atlanta more than $1.5 billion after finding that Johnson & Johnson and Pecos River Talc caused her malignant peritoneal mesothelioma. The award included about $59.84 million for medical expenses, lost wages and pain and suffering, and roughly $1.5 billion in punitive damages against both defendants.

Craft was 54 at the time of the verdict. Her attorneys argued that daily, long term use of the talc based baby powder contributed to an incurable cancer. Johnson & Johnson said it will appeal and criticized the verdict as the result of trial errors. Johnson & Johnson stopped selling talc based baby powder in 2023.

The size of the punitive award places the case among the largest single plaintiff verdicts in the ongoing wave of talc litigation nationwide. For Baltimore the immediate consequences are legal and economic. Local plaintiffs lawyers may see continued demand as mesothelioma and other talc related cases proceed through trial dockets. Local courts could face additional filings, which would extend timelines for related cases and affect court resources.

Market and corporate implications include greater pressure on Johnson & Johnson to settle remaining claims, to maintain litigation reserves, and to pursue appeals that could take years. Large punitive awards are often reduced on appeal, but the headline amount can influence settlement negotiations and insurance costs. For Baltimore area retailers and pharmacies the ruling reinforces the need to manage legacy inventories and customer inquiries, even though the manufacturer halted sales in 2023.

Public health and consumer signals are also significant. Residents who used talc based products in the past may wish to consult clinicians about possible symptoms and risks. Local health providers and community clinics may see increased demand for information and screening referrals. Policymakers and regulators could face renewed calls for review of product safety standards and labeling.

The verdict highlights the long term legal, financial and public health consequences of product liability cases. With an appeal looming, the final financial liability and broader regulatory responses will take shape over the coming months and possibly years.